The Preventive Infection Role of One Week Antibiotics Before Minimally Invasive Upper Tract Lithotomy
NCT02789579 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2019-10-01
Summary
Minimally invasive upper tract lithotomy is currently a common operation method on treatment of urinary tract stones, but the postoperative complication urinary tract infection or urinary sepsis has turned into a serious threat to the patient's life, when severe, can result in a higher death rate.Although more the more importance were attached to, an effective prevention measures still have not been found.
Among Urinary calculi, the higher rates of infection stone resulted in a higher incidence of postoperative urinary tract infection. The conventional postoperative prophylaxis medicine was the use of antimicrobial drugs half an hour before surgery.Foreign studies had shown that continuous preoperative one week use of nitrofurantoin can significantly reduce the incidence of urinary sepsis. So the investigators assume that preoperative extended use time of prophylaxis antibiotic may reduce the incidence of urinary tract infection or urinary sepsis.
This study uses a computerized random method. According to preoperative use of different antimicrobial drug or treatment, all patients are randomly divided into five groups, namely levofloxacin 3days group,levofloxacin 7days group, nitrofurantoin 3days group,nitrofurantoin 7days group and cefuroxime group.The levofloxacin group receives levofloxacin 0.5g, qd, po, the nitrofurantoin group was given oral nitrofurantoin 100mg, tid, po.to explore the better antibiotics types, medication timing and duration of treatment to prevent postoperative infection after minimally invasive upper tract lithotomy, so as to reduce the incidence of postoperative urinary tract infection or sepsis.
Conditions
- Complication of Surgical Procedure
Interventions
- DRUG
-
levofloxacin
There are 50 patients in the group,each patient receives levofloxacin 0.5g, qd, po 7 days before Minimally invasive upper tract lithotomy.All patients in all groups, 30 minutes before surgery, are given preventive medication cefuroxime 1.5g ivgtt, and continue using 1.5g q12h ivgtt until postoperative 48 hours.
- DRUG
-
Nitrofurantoin
There are 50 patients in the group,each patient receives nitrofurantoin 0.1g, qd, po 7 days before Minimally invasive upper tract lithotomy.All patients in all groups, 30 minutes before surgery, are given preventive medication cefuroxime 1.5g ivgtt, and continue using 1.5g q12h ivgtt until postoperative 48 hours.
- DRUG
-
cefuroxime
There are 150 patients in the group, 30 minutes before surgery, each patient is given preventive medication cefuroxime 1.5g ivgtt, and continue using 1.5g q12h ivgtt until postoperative 48 hours.
Sponsors & Collaborators
-
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
lead OTHER
Principal Investigators
-
li lixia, Master · Xinhua Hospital, Shanghai Jiaotong University School of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 16 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-30
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- China
Study Locations
More Related Trials
-
PRevention Of Trauma-related Infections Through an Embedded Clinical Trials Network
NCT06920147 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Prophylactic Antibiotic in Non-complicated Low Risk Lap Cholecystectomy (LC)
NCT06193837 ·Status: NOT_YET_RECRUITING
-
Interest in Probabilistic Antibiotic Therapy With Broad-spectrum Beta-lactams in Orthopedic Surgery
NCT06191601 ·Status: RECRUITING
-
Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP
NCT02098486 ·Status: COMPLETED ·Phase: PHASE2
-
Duration of Perioperative Antibiotics in Pancreatoduodenectomy
NCT07043855 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Performance of the SeptiCyte LAB Test for Antibiotic Stewardship in Mesenteric Ischemia
NCT06507423 ·Status: COMPLETED
-
Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome
NCT05302531 ·Status: RECRUITING ·Phase: PHASE1
-
Pharmacokinetics of Small Spectrum Beta-lactam Antibiotics (Amoxicillin/Clavulanic Acid and Cefuroxime) in Patients on Intensive Care Units
NCT01581047 ·Status: COMPLETED
-
Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli
NCT01820793 ·Status: TERMINATED ·Phase: NA
-
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.
NCT02852902 ·Status: COMPLETED
-
Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae
NCT01138566 ·Status: UNKNOWN
-
Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LC
NCT01265173 ·Status: COMPLETED ·Phase: PHASE4
-
Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital
NCT07255443 ·Status: NOT_YET_RECRUITING
-
Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation
NCT06782880 ·Status: RECRUITING ·Phase: NA
-
Precision Antibiotic Dosing for Appendectomy
NCT06860802 ·Status: RECRUITING ·Phase: PHASE1
-
Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments
NCT01703299 ·Status: COMPLETED
-
Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy
NCT05925309 ·Status: RECRUITING ·Phase: NA
-
Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria
NCT07345923 ·Status: RECRUITING
-
Empirical Antibiotic and Outcome in Community-onset Bacteremia
NCT03765749 ·Status: COMPLETED
-
The Value of Post-operative Antibiotic Therapy After Laparoscopic Appendectomy for Complicated Acute Appendicitis (Other Than for Generalized Peritonitis)
NCT03688295 ·Status: RECRUITING ·Phase: PHASE3
-
Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases
NCT02127450 ·Status: COMPLETED
-
A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections
NCT00952796 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections
NCT00860587 ·Status: UNKNOWN
-
Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures
NCT01524081 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Rapid Molecular Diagnostic Method on Antibiotics Exposure Duration in ICU Patients with Postoperative Peritonitis
NCT04925388 ·Status: TERMINATED ·Phase: NA